Notice - Prescription Drug List (PDL): Mometasone furoate
The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to allow the nonprescription use of Mometasone furoate for the conditions listed below. Only the Human part of the PDL was revised.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice - Prescription Drug List (PDL): Mometasone furoateHTMLEnglish publication HTML
-
Notice - Prescription Drug List (PDL): Mometasone furoateHTMLFrench publication HTML
Similar records